In 2013 industrial enterprises of the Chinese medicine research and development of product line

August 1, 2013

Sina finance and economics

        Research and development of product line award winners list:

        1,

        Companies adhere to scientific and technological innovation as the power, is committed to build the core competitiveness of the enterprise. Adhering to the "scientific research to create a healthy life" for the idea, to build the Chinese multinational pharmaceutical group as the overall goal, enterprising, innovation, constantly to reach the company for the development of new cross and new breakthrough.

        Perseverance, the h life. This is jiangsu hengrui medicine co., LTD.

        The second house

        The company spirit of "innovation as the soul" business philosophy, in science and technology as the guide, market-oriented under the guiding ideology, adhere to the characteristics of the road of scientific and technological innovation, accelerate the enterprise development continuously.

        The company is committed to "Chinese medicine modernization and internationalization of market, making the first brand of Chinese herbal medicine, make contributions to human health! This is step in shandong pharmaceutical co., LTD.

        3 home

        Across the region, trade and industry combination, the integration of national large pharmaceutical enterprise group, is a new technology state key laboratory of pharmaceutical preparations based on the construction unit. Companies adhering to the "being enterprising, sentient beings" protection concept, continuously to speed up the pace of scientific and technological innovation, the independent brand construction, build the core competitiveness, enterprise comprehensive economic strength get rapid ascension.

        This is the Yangtze river pharmaceutical group co., LTD.

        4 home

        Set of chemical, biological, pharmaceutical research, pharmaceutical intermediates, pharmaceutical, preparation manufacturing and product sales in the integration of innovative medicine group, the country's largest antitumor and psychiatric drugs research and development and production base. Attaches great importance to new product development, to undertake including major national drug discovery "special", "863 plan", "national innovation fund", more important, class 1 new drug application has more than 20 varieties.

        To "serve the community, create a healthy" for the purpose, and constantly transcend self. This is he pharmaceutical co., LTD., jiangsu.

        The fifth house

        Over the years has always been focused on liver disease drug research and development, continuous launched eight liver disease treatment of new drugs; Is given priority to with glycyrrhiza preparations of natural medicine research and development and application in the domestic leading position; Established the first domestic professional engaged in liver disease drug research and development of postdoctoral workstation.

        With "the human health, create a better future" for the purpose, committed to innovation, efforts to expand the international market. This is jiangsu zhengda pharmaceutical co., LTD., the weather is fine.

        6,

        Companies with "innovation is the fundamental driving force of the development of the enterprise" as development strategy, after years of development and efforts, the successful development of various kinds of new drugs more than 100. The company has world-class production equipment, adhering to the "make life more valuable" commitment, efforts to promote the development of Chinese medicine and health care.

        This is the zhuhai federal pharmaceutical co., LTD.

        The seventh house

        Ministry of science and technology of national key high-tech and technology enterprises, is a traditional Chinese medicine, chemical medicine, biological agents, and raw materials and production of integrated pharmaceutical group. The core competitiveness of science and technology is strong, is a leading, world-class pharmaceutical research and production base. The company always adhere to the "benefit society and create a better life" for the purpose.

        Young, aspire to the world. This is the southern shandong pharmaceutical group co., LTD.

        The eighth house

        Production, research and development, sales for the integration of new pharmaceutical group. New drug research and development to the market as the guidance, and focus on innovation has a broad potential market or the Chinese market first developed the generic brand. More than 20 currently in innovative drug research project, and all with independent intellectual property rights.

        Corporate goal is to become the leader of Chinese innovation in drug development, create innovative drugs in the field of major challenge. This is simcere pharmaceutical co., LTD.

        The ninth

        Companies adhere to the strategy of "science and technology enterprise", "comprehensive national new medicine r&d technology platform (shandong) industrialization demonstration enterprise", has a national local joint engineering laboratory.

        Adhere to the "prudential for this, the innovation" the guiding ideology, to create the biggest value space. This is shandong rossing pharmaceutical co., LTD.

        The 10th house

        Adhere to product innovation and optimization strategy for the development of innovative ability is the core of the company development and source, the country's largest production base of proton pump inhibitor injection and the kind of one of the most antitumor drug. Based on research for the source, health "for the idea, to create a brand.

        Ordered the livelihood of the people, the advanced, corning harmony, this is orsay kang pharmaceutical co., LTD., jiangsu province.

        11 home

        National first batch of innovative enterprises, committed to the integration of drug development and production of resources, currently a total of 18 products have been approved to enter the U.S. market, 14 ceps products. More than 80% of the API products are sold to more than 30 countries, especially in the United States and Europe have a leading market share.

        "Grasping drug innovation, achievement health dream" is the enterprise mission, "Mr Hainer health right fix far" is the enterprise spirit, this is zhejiang sea are pharmaceutical co., LTD.

        The 12th house

        Adhering to the "innovation, honest and trustworthy," the idea, in order to ensure patients life as own duty, committed to the independent research and development, production to fill the domestic blank and drugs with independent intellectual property rights.

        New, never stop: adhere to the science and technology enterprise, strive to build the enterprise independent innovation system. Honest and trustworthy, sincere cooperation, firmly believe that "honesty" is "and" in all things. This is Chen xin pharmaceutical co., LTD.

        13 home

        In antitumor and cardiovascular areas have many varieties of traditional Chinese medicine (TCM) advantage, enterprise technology centers recognized by the "national", "national innovative enterprise". Companies adhere to the "health, 100, 100, 100, the 100 quality, innovation" values, providing customers with high quality products that meet the requirements of environmental protection.

        This is beneficial in guizhou pharmaceutical co., LTD.

        14 home

        With domestic leading Chinese herbal medicine GAP pharmaceutical base, modern traditional Chinese medicine (TCM) digital manufacture platform, digital to extract the center and the nation's largest producing Chinese medicine injection production base. The biggest dropping pill dosage form manufacturer, phase III clinical compound danshen dropping pill to enter the United States. Domestic leading modern Chinese medicine research and development of enterprises, rich product line.

        Adhering to the "pursuit of harmony, improve the quality of life" business philosophy, adhere to create the first brand of modern traditional Chinese medicine (TCM), and continuously promote the sustained, rapid and healthy industry development. This is tianjin TianShiLi group co., LTD.

        At 15

        Collection of drug research and development, production, logistics, retail, and Chinese herbal medicine planting pharmaceutical enterprise at an organic whole, in r&d spending accounts for more than 5% annual sales revenue. In the aspect of cardio-cerebrovascular disease, gynecology and medicine for children has a strong advantage. "Do medicine attentively, benefit mankind" values, serve the community and dedication of love.

        Becoming a "world, talc, talc, one hundred", this is its vision, this is talc pharmaceutical group co., LTD.

        At 16

        National model enterprise for TCM modernization, as a key national high-tech enterprise and national innovative enterprises; Companies adhere to the scientific innovation as the forerunner, and constantly improve enterprise independent innovation strength. And drug research institute, YouJiSuo scientific research institutes to establish a joint laboratory.

        "Adhere to the healthy development of the innovative growth for both the sails", this is jiangsu kang pharmaceutical co., LTD.

        17th

        Always adhere to science and technology as the forerunner, take the market as the leading scientific and technological innovation development strategy, to create "theory - research - new drugs - production - sales" five one of the unique operation mode. With collaterals disease theory innovation impetus industrialization of traditional Chinese medicine, using the modern new and high technology research and development of modern Chinese medicine, western medicine and biological medicine.

        "Inherit the innovation for the benefit of humanity", this is shijiazhuang ridge pharmaceutical co., LTD.

        18 home

        Is a mainly engaged in gene engineering and biochemical drug research and development, production and operation of high-tech enterprises. Innovation, research and development and the market two countries with independent intellectual property rights, to a class of new drugs and 8 second grade national new medicine form tumors, geriatrics, liver disease as the leading product line.

        "Strives for the survival by the quality, seek development by innovation", that is double heron pharmaceutical co., LTD. In Beijing.

        19 home

        The domestic first developed genetic recombinant human growth hormone, high-tech enterprises, the first "genetic engineering drug quality management demonstration center", to the exploration of the dedicated, professional spirit and strong ability of independent innovation, become the leader in the field of children's growth and development treatment.

        "Dedicated to the health industry, to create human happiness", this is changchun Kinsey pharmaceutical co., LTD.

        20 home

        Using China before clinical trials of drug research and clinical trials unique resource advantages, integration of the world's resources, establish a "highway", new drug research and development to build new drug research and development of new ideas, new model and new standards. Its products by the complex is the world's first and so far the only by the Chinese people take the lead in the industrialization of the Nobel Prize in physiology or medicine.

        "With the national spirit to inspire people," this is the north road in xiamen biological engineering co., LTD.

The original link: http://finance.sina.com.cn/hy/20130801/172716316826.shtml

(the site editor Wang Zhong)